Cureskin Tranexamic Acid 10% Cream | 20,000 PPM Kojic Acid Dipalmitate, 15,000 PPM Alpha Arbutin, 100,000 PPM Tranexamic Acid | Dark spots, Freckle, Blemishes, Pigmentation (15g/0.5 Oz)
$10.48






Price: $10.48
(as of Aug 12, 2026 22:47:57 UTC – Details)
Product description







Package Dimensions : 3.9 x 1.34 x 1.26 inches; 1.13 ounces
Manufacturer : Cureskin
ASIN : B0DVHYFRPX
Best Sellers Rank: #69,989 in Beauty & Personal Care (See Top 100 in Beauty & Personal Care) #210 in Facial Night Creams
Customer Reviews: 3.9 3.9 out of 5 stars (143) var dpAcrHasRegisteredArcLinkClickAction; P.when(‘A’, ‘ready’).execute(function(A) { if (dpAcrHasRegisteredArcLinkClickAction !== true) { dpAcrHasRegisteredArcLinkClickAction = true; A.declarative( ‘acrLink-click-metrics’, ‘click’, { “allowLinkDefault”: true }, function (event) { if (window.ue) { ue.count(“acrLinkClickCount”, (ue.count(“acrLinkClickCount”) || 0) + 1); } } ); } }); P.when(‘A’, ‘cf’).execute(function(A) { A.declarative(‘acrStarsLink-click-metrics’, ‘click’, { “allowLinkDefault” : true }, function(event){ if(window.ue) { ue.count(“acrStarsLinkWithPopoverClickCount”, (ue.count(“acrStarsLinkWithPopoverClickCount”) || 0) + 1); } }); });
Targets multiple types of hyperpigmentation, including melasma, dark spots, and sun-induced pigmentation.
Combination of skin-brightening actives that work synergistically to enhance skin radiance.
Contains stabilised Vitamin C (Magnesium Ascorbyl Phosphate) for added antioxidant protection.
Gentle yet highly effective, making it suitable for daily use on sensitive skin.
Prevents new pigmentation formation by regulating melanin production.
Reduces Hyperpigmentation – Targets stubborn pigmentation, melasma, Brightens Skin Tone – Fades dark spots and evens out skin for a radiant glow.
User Reviews
Be the first to review “Cureskin Tranexamic Acid 10% Cream | 20,000 PPM Kojic Acid Dipalmitate, 15,000 PPM Alpha Arbutin, 100,000 PPM Tranexamic Acid | Dark spots, Freckle, Blemishes, Pigmentation (15g/0.5 Oz)”
$10.48
There are no reviews yet.